Gene-target recognition among members of the Myc superfamily and implications for oncogenesis

Nature Genetics

Volumn 24, Issue 2, 2000, Pages 113-119

  O'Hagan, Rónán C ^a   Schreiber Agus, Nicole ^c   Chen, Ken ^c   David, Gregory ^a   Engelman, Jeffrey A ^c   Schwab, Richard ^c   Alland, Leila ^c   Thomson, Cole ^c   Ronning, Donald R ^d   Sacchettini, James C ^d   Meltzer, Paul ^e   DePinho, Ronald A ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

^e NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; MOLECULAR RECOGNITION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; TUMOR CELL;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIVISION; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0033968093     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/72761     Document Type: Article

References (37)

1. Evan, G. & Littlewood, T.D. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3, 44-49 (1993).
2. Amati, B. & Land, H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4, 102-108 (1994).
3. Blackwood, E.M., Kretzner, L. & Eisenman, R.N. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2, 227-235 (1992).
4. Henriksson, M. & Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109-182 (1996).
5. Schreiber-Agus, N. & DePinho, R.A. Repression by the Mad(Mxi1)-Sin3 complex. Bioessays 20, 808-818 (1998).
6. Blackwell, T.K., Kretzner, L., Blackwood, E.M., Eisenman, R.N. & Weintraub, H. Sequence-specific DNA binding by the c-Myc protein. Science 250, 1149-1151 (1990).
7. Kretzner, L., Blackwood, E.M. & Eisenman, R.N. Myc and Max proteins possess distinct transcriptional activities. Nature 359, 426-429 (1992).
8. Ayer, D.E., Kretzner, L. & Eisenman, R.N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211-222 (1993).
9. Ferre d'Amare, A., Prendergast, G.C., Ziff, E.B. & Burley, S.K. Recognition of Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature 363, 38-45 (1993).
10. Grandori, C., Mac, J., Siebelt, F., Ayer, D.E. & Eisenman, R.N. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15, 4344-4357 (1996).
11. Solomon, D.L., Amati, B. & Land, H. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers. Nucleic Acids Res. 21, 5372-5376 (1993).
12. Halazonetis, T.D. & Kandil, A.N. Determination of the c-MYC DNA-binding site. Proc. Natl Acad. Sci. USA 88, 6162-6166 (1991).
13. Fisher, F. & Goding, C.R. Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif. EMBO J. 11, 4103-4109 (1992).
14. Hurlin, P.J., Queva, C. & Eisenman, R.N. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11, 44-58 (1997).
15. Greenberg, R.A. et al. Telomerase reverse transcriptase is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226 (1999).
16. Krikos, A., Laherty, C.D. & Dixit, V.M. Transcriptional activation and the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267, 17971-17976 (1992).
17. Chiorini, J.A., Miyamoto, S., Harkin, S.J. & Safer, B. Genomic cloning and characterization of the human eukaryotic initiation factor-2β promoter. J. Biol. Chem. 274, 4195-4201 (1999).
18. Dang, C.V. c-Myc target genes involved in cell growth, apoptosis and metabolism. Mol. Cell. Biol. 19, 1-11 (1999).
19. Grandori, C. & Eisenman, R.N. Myc target genes. Trends Biochem. Sci. 22, 177-181 (1997).
20. Felsher, D.W. & Bishop, J.M. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc. Natl Acad. Sci. USA 96, 3940-3944 (1999).
21. Lee, T.C., Li, L., Philipson, L. & Ziff, E.B. Myc represses transcription of the growth arrest gene gas1. Proc. Natl Acad. Sci. USA 94, 12886-12891 (1997).
22. Marhin, W.M., Chen, S., Facchini, L.M., Fornace, A.J. Jr & Penn, L.Z. Myc represses the growth arrest gene gadd45. Oncogene 14, 2825-2834 (1997).
23. Wu, K.J., Polack, A. & Dalla-Favera, R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-Myc. Science 283, 676-679 (1999).
24. Li, L.H., Nerlov, C., Prendergast, G., MacGregor, D. & Ziff, E.B c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13, 4070-4079 (1994).
25. Lee, L.A. & Dang, C.V. c-Myc transrepression and cell transformation. Curr. Top. Microbiol. Immunol. 224, 131-135 (1999).
26. Kauffmann-Zeh, A. Suppression of c-Myc-induced apoptosis by Ras signalling through Pl(3)K and PKB. Nature 385, 544-548 (1997).
27. Mukherjee, B., Morgenbesser, S.D. & DePinho, R.A. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants. Genes Dev. 6, 1480-1492 (1992).
28. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. & Pease, L.R. Site directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (1989).
29. Schreiber-Agus, N. et al. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777-786 (1995).
30. Jones, T.A., Zou, J.Y. & Kjeldgaard, M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119 (1991).
31. Ferre-D'Amare, A.R., Pognonec, P., Roeder, R.G. & Burley, S.K. Structure and function of the b/HLH/Z domain of USF. EMBO J. 13, 180-189 (1994).
32. Shimizu, T. et al. Crystal structure of PHO4 bHLH domain-DNA complex: flanking base recognition. EMBO J. 16, 4689-4697 (1997).
33. Christopher, J.A. SPOCK: The Structural Properties Observation and Calculation Kit (Texas A & M University, The Center for Macromolecular Design, College Station, 1998).
34. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. & Lowe, S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
35. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
36. Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009-5013 (1998).
37. Chen, Y., Dougherty, E.R. & Bittner, M.L. Ratio-based decisions and the quantitative analysis of cDNA microarray images. J. Biomed. Optics 2, 364-374 (1997).